DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Teradata Corp
TDC
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -14.35%20.71M | 24.35%22.89M | 46.93%25.2M | -43.43%77.15M | -46.75%17.42M | -31.27%24.18M | -53.79%18.4M | -40.17%17.15M | 84.98%136.38M | 22.40%32.71M |
Net income from continuing operations | -97.61%203K | 210.29%2.81M | -87.75%10.27M | -1,256.12%-103.99M | -769.48%-193.73M | -84.78%8.48M | -110.40%-2.55M | 227.79%83.81M | -114.61%-7.67M | -181.93%-22.28M |
Operating gains losses | -89.18%543K | -104.81%-328K | 107.00%1.05M | -111.41%-23.18M | -128.70%-19.96M | 849.10%5.02M | -75.47%6.82M | -114.13%-15.06M | 1,220.93%203.21M | 874.82%69.56M |
Depreciation and amortization | 27.85%13.57M | -10.49%10.33M | -3.85%10.52M | 7.07%44.29M | 1.41%11.19M | 0.04%10.62M | 16.16%11.54M | 11.84%10.94M | 3.70%41.36M | -6.76%11.04M |
Other non cash items | 425.17%3.32M | 24.18%5.69M | 103.36%2.63M | 11.72%-73.47M | 106.15%1.11M | 96.12%-1.02M | 118.09%4.58M | -478.00%-78.14M | -2,137.38%-83.23M | -180,400.00%-18.03M |
Change In working capital | 910.27%1.48M | 186.47%2.55M | -102.75%-411K | 138.39%6.64M | 27.15%-5.51M | 103.53%146K | -200.48%-2.95M | 275.37%14.96M | -147.40%-17.3M | -31.89%-7.57M |
-Change in receivables | -170.85%-6.63M | 16.91%1.53M | -89.77%2.1M | 186.51%19.68M | 109.70%295K | -151.49%-2.45M | 113.44%1.31M | 239.28%20.53M | -53.62%-22.75M | 76.36%-3.04M |
-Change in other current assets | 263.31%1.36M | -75.41%947K | 63.67%-1.07M | 90.01%-546K | -258.10%-615K | 79.21%-834K | 610.74%3.85M | -170.71%-2.95M | -247.93%-5.47M | 128.82%389K |
-Change in other current liabilities | 96.67%6.74M | 100.93%75K | 45.04%-1.44M | -214.46%-12.49M | -5.66%-5.19M | 170.23%3.43M | -160.45%-8.11M | -135.91%-2.62M | 16.28%10.92M | -170.62%-4.92M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -14.35%20.71M | 24.35%22.89M | 46.93%25.2M | -43.43%77.15M | -46.75%17.42M | -31.27%24.18M | -53.79%18.4M | -40.17%17.15M | 84.98%136.38M | 22.40%32.71M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,862.27%-234.53M | -118.91%-35.47M | 75.65%-3.02M | 46.67%-46.22M | 64.97%-5.69M | 80.89%-11.95M | -668.96%-16.2M | -113.76%-12.38M | 61.95%-86.67M | 92.14%-16.23M |
Net PPE purchase and sale | -8,911.35%-231.86M | -379.06%-30.1M | 83.68%-180K | 83.45%-10.42M | -23.92%-461K | 95.48%-2.57M | -943.85%-6.28M | 78.36%-1.1M | 71.31%-62.95M | 99.82%-372K |
Net other investing changes | 71.55%-2.67M | 45.93%-5.36M | 74.86%-2.84M | -50.92%-35.8M | 67.05%-5.22M | -65.59%-9.38M | -559.00%-9.92M | -1,520.40%-11.28M | -183.33%-23.72M | -2,083.88%-15.86M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -1,862.27%-234.53M | -118.91%-35.47M | 75.65%-3.02M | 46.67%-46.22M | 64.97%-5.69M | 80.89%-11.95M | -668.96%-16.2M | -113.76%-12.38M | 61.95%-86.67M | 92.14%-16.23M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,414.65%141.67M | 1,776.87%84.01M | -228.93%-22.12M | 25.85%-35.63M | 28.81%-13.12M | -135.34%-10.78M | 88.88%-5.01M | 55.36%-6.72M | -134.40%-48.05M | -110.54%-18.43M |
Net issuance payments of debt | 3,600.00%148M | -235.71%-19M | 98.23%-2M | -187.50%-92M | 125.00%3M | -87.88%4M | 136.84%14M | -653.33%-113M | -420.00%-32M | -126.67%-12M |
Net common stock issuance | --18.75M | --122.5M | --0 | --106.28M | --0 | --0 | --0 | --106.28M | --0 | --0 |
Cash dividends paid | -48.72%-21.95M | -6.80%-20.19M | ---19.45M | -277.47%-49.76M | -140.19%-16.1M | ---14.76M | ---18.9M | --0 | -9,384.17%-13.18M | -4,722.30%-6.7M |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1.03M | ---- |
Net other financing activities | -20,733.33%-3.13M | 739.45%697K | -66,500.00%-666K | 96.31%-144K | 97.48%-19K | 99.40%-15K | 80.91%-109K | 98.44%-1K | -37.68%-3.9M | 72.48%-755K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,414.65%141.67M | 1,776.87%84.01M | -228.93%-22.12M | 25.85%-35.63M | 28.81%-13.12M | -135.34%-10.78M | 88.88%-5.01M | 55.36%-6.72M | -134.40%-48.05M | -110.54%-18.43M |
Net cash flow | ||||||||||
Beginning cash position | 1,611.69%76M | -36.95%4.57M | -51.05%4.51M | 21.96%9.2M | -47.16%5.89M | -44.65%4.44M | -52.80%7.25M | 21.96%9.2M | -65.59%7.55M | -10.31%11.15M |
Current changes in cash | -5,072.64%-72.15M | 2,643.77%71.43M | 103.32%65K | -383.58%-4.7M | 28.70%-1.39M | -53.60%1.45M | 61.72%-2.81M | -125.05%-1.96M | 111.52%1.66M | 60.18%-1.94M |
End cash Position | -34.71%3.85M | 1,611.69%76M | -36.95%4.57M | -51.05%4.51M | -51.05%4.51M | -47.16%5.89M | -44.65%4.44M | -52.80%7.25M | 21.96%9.2M | 21.96%9.2M |
Free cash flow | -1,077.28%-211.15M | -159.60%-7.22M | 55.91%25.02M | -8.73%66.73M | -47.04%16.96M | 199.57%21.61M | -69.10%12.12M | -31.92%16.05M | 150.18%73.11M | 117.89%32.02M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |